Display Settings:   Send to:  Choose Destination   Author
information    • Department of Pediatrics, Human Early Learning
Partnership, Faculty of Graduate Studies, University of British
Columbia, Vancouver. toberlander@cw.bc.ca    Prenatal exposure
to selective serotonin reuptake inhibitor (SSRI) antidepressants
and maternal depression both alter neonatal health, and
distinguishing the effects of each influence remains
challenging.   To determine whether exposure to SSRIs and
depression differs from exposure to maternal depression alone.
Using population health data, records of neonatal birth outcomes
were linked to records of maternal health and prenatal maternal
prescriptions for SSRIs.   Population of British Columbia,
Canada.   Mothers and their infants, representing all live
births during a 39-month period (N = 119,547) (1998-2001).
Outcomes from infants of depressed mothers treated with SSRIs
(SE-D) were compared with outcomes from infants of depressed
mothers not treated with medication (DE) and no